Key areas of research
Cancer Expert Prof. Dr. Richard Greil is one of the most cited physicians in the world, which underlines his important role in the scientific community and his contribution to medical research. His numerous publications in prestigious journals have been recognized worldwide and are frequently cited by other researchers and physicians. This demonstrates not only the quality and relevance of the Cancer Expert’s work, but also the impact of his research on the field of oncology and beyond.
In particular, his work on leukemias, lymphomas, and solid tumors, as well as his contributions to the development of new therapies and precision medicine, have contributed significantly to making him one of the most cited cancer experts. Prof. Dr. Greil’s research findings have provided new insights that have improved clinical practice and advanced innovative treatment methods.
The high citation frequency of his work also reflects the importance of his research to the scientific community and shows that his findings are valued and used by colleagues worldwide to advance oncology research and treatment.
Awards
The Cancer Expert has been awarded the Grand Cross of Merit in Silver for services to the Republic of Austria.
Career / Curriculum
1983
Medical studies at the Leopold Franzens University of Innsbruck
Doctorate awarded sub auspiciis praesidentis rei publicae Austriae
1990
Board Certification for Internal Medicine
1992
Habilitation in internal medicine at the Leopold Franzens University of Innsbruck
1995
Board Certification for Hematology and Medical Oncology
1997
Appointed Associate Professor at the Leopold Franzens University of Innsbruck
Deputy Director of the Division of Hematology and Medical Oncology at the Leopold Franzens University of Innsbruck
1998
Founding member of the Tyrolean Cancer Research Institute
2001-2004
Scientific Director of the Tyrolean Cancer Research Institute
2004
Head of the III Medical University Clinic in Salzburg, comprising Hematology, Medical Oncology, Hemostasis, Infectious Diseases, and Rheumatology; Oncology Center at the Paracelsus Medical Private University Salzburg
Founder and Managing Director of the Center for Clinical Cancer and Immunology Trials (CCCIT) at the III Medical University Clinic (now Salzburg Cancer Research Institute – CCCIT GmbH)
2005
Founder and Managing Director of the Laboratory for Immunological and Molecular Cancer Research of the Salzburg Cancer research Institute (SCRI-LIMCR Gmbh)
And Founder of the Laboratory for Molecular Cytology at the IIIrd Medical University Salzburg
Additional Board Certification in Rheumatology
2004 ff
President and Scientific Director of the “Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)-GesmbH”
Vice President of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
2007
Additional Board Certification in Infectious Diseases and Tropical Medicine
Establishment and leadership of the Stem Cell Laboratory at the IIIrd Medical University Clinic Salzburg
2012-2017
Vice President of the Austrian Society for Hematology and Oncology (ÖGHO)
2013
Founder and scientific director of the Salzburg Cancer Research Institute GmbH
2013 ff
Founder and Director of the Cancer Cluster Salzburg (an interinstitutional collaboration between SCRI-LIMCR GmbH, SCRI-CCCIT GmbH, the Salzburg University Hospitals (SALK), and the Paris Lodron University of Salzburg)
2013-14
Medical Director of the Oncology Rehabilitation Center in St. Veit im Pongau
2017
Honorary Professor at the Faculty of Natural Sciences, Paris Lodron University of Salzburg
2019
Head of the Working Group for Research and Science within the PREVENIRE project for developing the White Paper on Austria’s Healthcare System 2030
2020/March
Medical Director of the COVID-19 Crisis Team of the Salzburg University Hospitals (SALK) until 22 April 2020
Medical Director of the COVID-19 Crisis Team of the Province of Salzburg until 22 April 2020
Recipient of the International Grand Prize for Science and Research of the City of Salzburg
Founder and Scientific Managing Director of the Austrian Cancer Research and Development GmbH
2021/June
Awarded the Grand Silver Medal of Merit of the Republic of Austria for services to the nation
2024
Founding of the IIT (Institute for Individualized Immunotherapy Research and Development) Gmbh
My management functions
Head of the Salzburg Cancer Research Institute (SCRI-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR); SCRI Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT)
Find out more
Head of the Cancer Cluster Salzburg
Find out more
Head of the Austrian Group for Medical Tumor Therapy (AGMT)
Find out more
2004 to 2024 Head of the III MedicalDepartment with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg
2004 to 2024 Head of Oncologic Center, Private Medical University Hospital Salzburg
Publications and scientific bibliometrics of the Cancer Expert
- Number of peer-reviewed publications: 671 (pubmed, 09/2024)
- H-factor*: 110 (Google Scholar, 09/2024)
- Frequency of citations of the publications: 55085 (Google Scholar, m09/2024)
- 6 publications have been cited over 1,000 times each (“Citation Classics”), one of them over 2,000 times.
- Most cited hematologist and oncologist in German-speaking countries between 2010-2014 according to the analysis of the newspaper Labormedizin (November 2017)
- Highly cited Researcher (Clarivate) 2021 and 2022 (i.e. one of the world’s most cited researchers in the field of clinical medicine)
*The H-factor (Hirsch factor) ranks the number of publications according to their citations. This balances out a few extremely frequently cited works. An H-factor of 110 means that the median number of citations of all publications is 110 per publication.
Scientific prizes (excerpt)
- Science Prize of the Tyrolean Medical Association
- Wolfgang Denk Prize of the Austrian Society for Hematology and Oncology (OeGHO) (1988, 2008)
- Wilhelm Türk Prize of the Austrian Society for Hematology and Oncology (OeGHO) (1991, 2010, 2013)
- Science Prize of the HöchstFoundation (1989)
- Science Prize of the Sanofi-Aventis Foundation of Paracelsus Medical University Salzburg (2009, two prizes, 2010; 2011; 2013 two prizes; 2014, two prizes)
- Best publishing clinic at Paracelsus Medical University Salzburg/SALK (2008, 2009, 2010, 2011, 2014, evaluation discontinued after 2014)
- Young Investigators Award of the Austrian Society of Hematology (OeGHO), Spring Conference (2011, 2012, 2014, 2 prizes; 2015, 2 prizes) in 2010 1 prize (2011, 2012, 2014, 2 prizes; 2015, 2 prizes)
Selection of invited lectures
2009
European Society of Medical Oncology (ESMO)/ECCO Meeting Berlin – “Individualized cancer therapy: The Pro and Con Debate”
2010
Educational Session at the Annual Conference of the Austrian, German and Swiss Societies of Hematology and Oncology – New substances in the treatment of CLL
2011
The Feinstein Institute in New York – The Role of the Microenvironment in CLL
2012
Early Breast Cancer Conference Vienna (EBCC) – The Management of Her2/neu overexpression in breast cancer
2014
The Pharmacogenomics Working Party of the European Medicine Agency (EMA), Salzburg – Pharmacogenomics and Pharmacogenetics in Oncology: Critical Comments in the era of transition towards personalized medicine
American Society of Hematology Meeting, oral presentation – “Mabtenance treatment in CLL, AGMT 8a Mabtenance trial”
2022
European Society of Medical Oncology Meeting, Paris – Educational Lecture: Her2 low positive Breast Cancer
Reviewer for scientific journals
Lancet, Lancet Oncology, JAMA Oncology, Ann Oncology, Lancet Haematology, J Experimental Medicine, Blood, Leukemia, Cancer Research, J Immunology, Oncogene, Ann Oncology, Int J Cancer, Eur J Haematology, Haematologica, J Hematology and Oncology, Carcinogenesis, Cancer Letters, Transplantation, Quality of Life Research, Gerontology, Oncology, Pharmacoeconomics, Respiration, Oncology, Biochemical Pharmacology, Breast Care and many others.
Cancer Expert Prof. Dr. Richard Greil is one of the most cited physicians in the world, underscoring his crucial role in the scientific coommunity and his contribution to medical research.
His work, particularly in the fields of leukemias, lymphomas, and solid tumors, as well as his significant profound contribution to the development of novel therapies and precision medicine, has not only shaped the field of oncology but has also provided new insights and improved clinical practice with innovative treatment methods.
The high citation frequency of his numerous publications highlights the importance of his research for the global scientific community. His findings are consistently referenced and utilized by researchers and clinicians worldwide, thereby advancing both oncology research and treatment methodologies.